Custom Search Insider Trading Activity Insider Trading Activity
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Custom Search Insider Trading Activity
Updated Mar 25, 2024
Ticker
|
Company Name
|
Qty.
|
Price
|
Size ($)
|
Filing Date
|
Type
|
Δ Own
|
Own
|
Insider Names
|
Title
|
Trade Dates
|
Is Scheduled
| |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Lenz Therapeutics, Inc.
|
0
|
—
|
—
|
—
|
0
|
Mar 21
| |||||||
Lenz Therapeutics, Inc.
|
0
|
—
|
—
|
—
|
0
| ||||||||
908 Devices Inc.
| 508 |
—
|
—
| +7.09% | 7.67K |
Feb 22
| |||||||
908 Devices Inc.
| 4.77K |
—
|
—
| +199.29% | 7.17K |
Jun 14 - Jun 15
| |||||||
Amneal Pharmaceuticals, Inc.
| 80.13K |
—
|
—
| +70.94% | 193.08K |
May 9 - May 10
| |||||||
908 Devices Inc.
| 507 |
—
|
—
| +26.87% | 2.39K |
Feb 22
| |||||||
908 Devices Inc.
| 1.38K |
—
|
—
| +271.46% | 1.89K |
Jun 15 - Jun 16
| |||||||
Amneal Pharmaceuticals, Inc.
| 35.41K |
—
|
—
| +45.66% | 112.96K |
May 8 - May 9
| |||||||
908 Devices Inc.
| 508 |
—
|
—
|
∞
| 508 |
Feb 22
| |||||||
908 Devices Inc.
|
0
|
—
|
—
|
—
|
0
|
Jun 17
| |||||||
Amneal Pharmaceuticals, Inc.
| 46.22K |
—
|
—
| +147.51% | 77.55K |
May 5 - May 6
| |||||||
908 Devices Inc.
|
0
|
—
|
—
|
—
|
0
|
Mar 1
| |||||||
908 Devices Inc.
|
0
|
—
|
—
|
—
|
0
| ||||||||
Amneal Pharmaceuticals, Inc.
| 7.52K |
—
|
—
| +31.59% | 31.33K |
Dec 15
| |||||||
Amneal Pharmaceuticals, Inc.
| 23.81K |
$4.16 | $99,049.60 |
∞
| 23.81K |
May 15
| |||||||
Amneal Pharmaceuticals, Inc.
|
0
|
—
|
—
|
—
|
0
|
May 5
| |||||||
Amneal Pharmaceuticals, Inc.
|
0
|
—
|
—
|
—
|
0
|
Dec 14
| |||||||
Amneal Pharmaceuticals, Inc.
|
0
|
—
|
—
|
—
|
0
| ||||||||
It looks like there's no data for these filter options. Maybe you'll be interested in these options instead. | |||||||||||||